Oral albendazole for the treatment of cutaneous larva migrans

Br J Dermatol. 1990 Jan;122(1):99-101. doi: 10.1111/j.1365-2133.1990.tb08245.x.


Cutaneous larva migrans is becoming more common in the U.K. with the popularity of tropical countries as holiday destinations. We describe the increasing use of a new benzimidazole derivative, albendazole, which is very effective in the treatment of cutaneous larva migrans. In contrast to thiabendazole, it is virtually free from side-effects and should, we feel, become the treatment of choice for this condition.

MeSH terms

  • Administration, Oral
  • Albendazole / administration & dosage
  • Albendazole / therapeutic use*
  • Breast / parasitology
  • Buttocks / parasitology
  • Humans
  • Larva Migrans / drug therapy*
  • Larva Migrans / parasitology
  • Leg Dermatoses / drug therapy
  • Leg Dermatoses / parasitology


  • Albendazole